James T. Borello
IONS icon

James T. Borello’s Ionis Pharmaceuticals IONS Stock Holding History

James T. Borello’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-7
Closed -$555 – 1310
2026
Q2 		$555 Buy
7
+3
+75% +$226 ﹤0.01% 1057
2026
Q1 		$300 Buy
+4
New +$316 ﹤0.01% 1083

Other funds holding IONS

Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Nippon Life Global Investors Americas
Nippon Life Global Investors Americas New York $2.51B AUM 38.65% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Motley Fool Asset Management
Motley Fool Asset Management Alexandria, Virginia $2.64B AUM 26.58% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

James T. Borello's IONS Position: Q3 2026 in Review

James T. Borello sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 7 shares — an estimated $555 sold.

James T. Borello first reported a position in IONS in Q1 2026 and held it in 2 quarters. The position peaked at $555 in Q2 2026. 100 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • James T. Borello reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • James T. Borello sold 7 Ionis Pharmaceuticals shares in Q3 2026, an estimated $555.
  • James T. Borello first reported a position in Ionis Pharmaceuticals in Q1 2026 and held it in 2 quarters.
  • James T. Borello's Ionis Pharmaceuticals position peaked at $555 in Q2 2026.
  • 100 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on James T. Borello's 13F filing for Q3 2026, filed 16 Oct 2026.